德琪医药-B(06996)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06996 德琪医药-B

休市中 12-05 16:09:08

4.430

+0.080

+1.84%

最高4.480	最低4.150	成交量210.35万
今开4.150	昨收4.350	日振幅7.59%
总市值30.08亿	流通市值30.08亿	总股本6.79亿
成交额917.35万	换手率0.31%	流通股本6.79亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06996","market":"HK","secType":"STK","nameCN":"德琪医药-B","latestPrice":4.43,"timestamp":1764922148007,"preClose":4.35,"halted":0,"volume":2103500,"delay":0,"floatShares":679000000,"shares":679000000,"eps":-0.5667110121834444,"marketStatus":"休市中","change":0.08,"latestTime":"12-05 16:09:08","open":4.15,"high":4.48,"low":4.15,"amount":9173521,"amplitude":0.075862,"askPrice":4.43,"askSize":2500,"bidPrice":4.41,"bidSize":7500,"shortable":3,"etf":0,"ttmEps":-0.4053077615625948,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765157400000},"marketStatusCode":7,"adr":0,"listingDate":1605801600000,"exchange":"SEHK","adjPreClose":4.35,"openAndCloseTimeList":[[1764898200000,1764907200000],[1764910800000,1764921600000]],"volumeRatio":0.7938666919998597,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06996","defaultTab":"news","newsList":[{"id":"2589852755","title":"交银国际：中国医药1-8批国采接续规则或温和 短期催化剂充足","url":"https://stock-news.laohu8.com/highlight/detail?id=2589852755","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589852755?lang=zh_cn&edition=full","pubTime":"2025-12-05 10:18","pubTimestamp":1764901122,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，交银国际发布研报称，本周恒生医疗保健指数涨0.5%，跑输大市。其中，生物药、处方药及器械板块表现较优于其他板块。本周内资偏向防御，倾向获利了结，主要加仓内生增长稳定的传统及低估创新药厂。而外资则较积极，聚焦创新主线中的龙头及产业链上游，包括创新药及CXO标的。1-8批集采接续采购规则转变为询价模式，交银国际认为此规则下整体降价幅度或有限，对港股处方药厂的影响或小于预期。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1378013.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK0188","BK0010","03329","BK1588","06996","BK0082","BK1161","600056","BK1141","BK1587","BK0250","BK1593","02096","BK1147","02268","SG9999014674.SGD","BK1583","BK1574","01530","BK0175","HK0000165453.HKD","BK0185","LU2488822045.USD","BK0028","00013"],"gpt_icon":0},{"id":"1171152247","title":"德琪医药（6996）更新11月股份变动月报，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1171152247","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1171152247?lang=zh_cn&edition=full","pubTime":"2025-12-04 18:26","pubTimestamp":1764843997,"startTime":"0","endTime":"0","summary":"德琪医药有限公司于2025年12月4日公布2025年11月股份变动月报。报告期截至2025年11月30日，公司注册股本维持在2,000,000,000股普通股，面值每股0.0001美元，总注册股本为200,000美元。期末已发行股份总数为679,244,132股，库存股份202,500股，整体保持不变。公司于报告期内未新增发行股份，亦未进行股份回购或注销。截至本月底，2020年股权激励计划及2022年受限制股份单位计划合计行使后可能发行的股份总数为55,780,257股。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06996"],"gpt_icon":0},{"id":"2588019668","title":"德琪医药-B(06996)：希维奥®在香港获批用于治疗多发性骨髓瘤及弥漫大B细胞淋巴瘤两种新增适应症","url":"https://stock-news.laohu8.com/highlight/detail?id=2588019668","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588019668?lang=zh_cn&edition=full","pubTime":"2025-12-03 16:38","pubTimestamp":1764751139,"startTime":"0","endTime":"0","summary":"智通财经APP讯，德琪医药-B(06996)公布，香港特别行政区政府卫生署已批准希维奥® (塞利尼索)的两项补充新药上市申请(sNDA)，批准希维奥®联合硼替佐米和地塞米松(XVd)用于治疗既往接受过至少一种治疗的多发性骨髓瘤(MM)成年患者;及希维奥®作为单药用于治疗复发性或难治性弥漫大B细胞淋巴瘤(rrDLBCL)成人患者，除另有说明外，其包含接受过至少两线系统性治疗且不符合造血干细胞移植的由滤泡性淋巴瘤引起的弥漫大B细胞淋巴瘤(DLBCL)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1377039.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"德琪医药-B(06996)：希维奥®在香港获批用于治疗多发性骨髓瘤及弥漫大B细胞淋巴瘤两种新增适应症","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK1574","06996","BK1583"],"gpt_icon":0},{"id":"1114028107","title":"港股生物医药股午后跌幅持续扩大，歌礼制药-B跌超11%","url":"https://stock-news.laohu8.com/highlight/detail?id=1114028107","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1114028107?lang=zh_cn&edition=full","pubTime":"2025-12-03 13:12","pubTimestamp":1764738746,"startTime":"0","endTime":"0","summary":"12月3日，港股生物医药股午后跌幅持续扩大，$歌礼制药-B(01672)$跌超11%，$华领医药-B(02552)$跌近8%，$迈博药业-B(02181)$跌近7%，$德琪医药-B(06996)$跌超5%，$亚盛医药-B(06855)$跌超4%。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c54c8d8de852bbfb4567c558a904e399","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01672","BK1161","02552","01477","BK1515","BK1191","06855","06996","BK1574","BK1583","02181"],"gpt_icon":0},{"id":"1182645191","title":"德琪医药-B在中国获得Atg-022（Cldn18.2 ADC）联合使用Keytruda®（Pembrolizumab）±化疗的I b/I II期研究的IND批准","url":"https://stock-news.laohu8.com/highlight/detail?id=1182645191","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182645191?lang=zh_cn&edition=full","pubTime":"2025-12-02 17:00","pubTimestamp":1764666030,"startTime":"0","endTime":"0","summary":"德琪医药-B在中国获得Atg-022（Cldn18.2 ADC）联合使用Keytruda®（Pembrolizumab）±化疗的I b/I II期研究的IND批准","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","06996","BK1583","BK1191"],"gpt_icon":0},{"id":"2588035332","title":"德琪医药-B(06996)：ATG-022联合KEYTRUDA®(帕博利珠单抗)±化疗的IB/II期研究于中国获授予IND批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2588035332","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588035332?lang=zh_cn&edition=full","pubTime":"2025-12-02 16:45","pubTimestamp":1764665132,"startTime":"0","endTime":"0","summary":"智通财经APP讯，德琪医药-B(06996)发布公告，中国国家药品监督管理局(国家药监局)已批准用于评估 ATG-022(CLDN18.2抗体药物偶联物ADC)联 合 MSD (Merck & Co., Inc., Rahway, NJ, USA)的抗PD 1疗法KEYTRUDA®(帕博利珠单抗)以及ATG-022联合帕博利珠单抗及化疗的Ib/II期CLINCH-2研究的研究性新药(IND)申请。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1376522.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK1574","IND","06996","BK1583"],"gpt_icon":0},{"id":"2588765720","title":"每日卖空追踪 | 德琪医药-B 12月01日卖空量成交11.15万股，卖空比例为3.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588765720","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588765720?lang=zh_cn&edition=full","pubTime":"2025-12-01 16:30","pubTimestamp":1764577836,"startTime":"0","endTime":"0","summary":"德琪医药-B北京时间12月01日，跌1.33%，卖空量成交11.15万股，较上一交易日减少68.23%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201163601a4c55275&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201163601a4c55275&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1574","06996","BK1583"],"gpt_icon":0},{"id":"2588720227","title":"德琪医药-B盘中异动 快速下挫5.09%报4.290港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2588720227","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588720227?lang=zh_cn&edition=full","pubTime":"2025-12-01 13:25","pubTimestamp":1764566737,"startTime":"0","endTime":"0","summary":"2025年12月01日下午盘13时25分，德琪医药-B股票出现波动，股价急速下挫5.09%。截至发稿，该股报4.290港元/股，成交量149.4万股，换手率0.22%，振幅7.74%。资金方面，该股资金流入249.304万港元，流出369.019万港元。德琪医药-B股票所在的药品行业中，整体跌幅为0.39%。其相关个股中，天大药业、康哲药业、白花油涨幅较大，振幅较大的相关个股有三爱健康集团、海王英特龙、德琪医药-B，振幅分别为12.50%、7.75%、7.52%。该公司主要在亚太地区开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512011325379523f9c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512011325379523f9c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06996","BK1191","BK1574","BK1583"],"gpt_icon":0},{"id":"2588156743","title":"医药生物行业周报：关注血液净化器械领域国产替代机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2588156743","media":"光大证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588156743?lang=zh_cn&edition=full","pubTime":"2025-12-01 00:00","pubTimestamp":1764518400,"startTime":"0","endTime":"0","summary":"血液净化类高值医用耗材市场，进口产品占据70%以上的市场份额。透析机和透析器技术壁垒相对较高，我国市场仍是外资主导；透析管路国内产品的市占率接近50%，透析粉/液已基本实现进口替代。建议关注国产血液净化器械领域龙头公司山外山、威高血净、宝莱特、健帆生物、三鑫医疗、天益医疗等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201105635a71bd540&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201105635a71bd540&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2097828714.EUR","LU2097828631.EUR","BK1589","LU2097828557.USD","BK1583","LU2328871848.SGD","LU2242644610.SGD","06996","HK0000165453.HKD","LU0455707207.USD","BK1161","LU0502904849.HKD","LU2097828474.EUR","LU1969619763.USD","01801","LU2097828805.USD","LU2488822045.USD"],"gpt_icon":0},{"id":"2584131925","title":"每日卖空追踪 | 德琪医药-B 11月20日卖空量成交12.75万股，卖空比例为8.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584131925","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584131925?lang=zh_cn&edition=full","pubTime":"2025-11-20 16:30","pubTimestamp":1763627436,"startTime":"0","endTime":"0","summary":"德琪医药-B北京时间11月20日，涨6.44%，卖空量成交12.75万股，较上一交易日增加25%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251120163745a4aecd15&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251120163745a4aecd15&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","06996","BK1583","BK1574"],"gpt_icon":0},{"id":"2584319011","title":"德琪医药-B盘中异动 临近收盘股价大涨5.78%报4.760港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584319011","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584319011?lang=zh_cn&edition=full","pubTime":"2025-11-20 15:48","pubTimestamp":1763624906,"startTime":"0","endTime":"0","summary":"2025年11月20日临近收盘15时48分，德琪医药-B股票出现波动，股价大幅拉升5.78%。截至发稿，该股报4.760港元/股，成交量148.05万股，换手率0.22%，振幅5.56%。资金方面，该股资金流入325.322万港元，流出298.486万港元。德琪医药-B股票所在的药品行业中，整体跌幅为0.43%。其相关个股中，华控康泰、君圣泰医药-B、德琪医药-B涨幅较大，振幅较大的相关个股有华控康泰、君圣泰医药-B、精优药业，振幅分别为22.22%、9.96%、9.20%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251120154826a4aeaf02&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251120154826a4aeaf02&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1574","06996","BK1191"],"gpt_icon":0},{"id":"2584024907","title":"每日卖空追踪 | 德琪医药-B 11月19日卖空量成交5.6万股，卖空比例为6.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584024907","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584024907?lang=zh_cn&edition=full","pubTime":"2025-11-19 16:30","pubTimestamp":1763541034,"startTime":"0","endTime":"0","summary":"德琪医药-B北京时间11月19日，涨1.58%，卖空量成交5.6万股，较上一交易日减少86.21%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119163615a703de05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119163615a703de05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1191","06996","BK1583"],"gpt_icon":0},{"id":"2584989410","title":"德琪医药-B盘中异动 大幅下跌5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584989410","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584989410?lang=zh_cn&edition=full","pubTime":"2025-11-18 14:28","pubTimestamp":1763447334,"startTime":"0","endTime":"0","summary":"2025年11月18日下午盘14时28分，德琪医药-B股票出现异动，股价急速下挫5.12%。德琪医药-B股票所在的药品行业中，整体跌幅为0.40%。其相关个股中，精优药业、雅各臣科研制药、培力农本方涨幅较大，振幅较大的相关个股有三爱健康集团、精优药业、中国同辐，振幅分别为23.08%、18.99%、8.31%。德琪医药-B公司简介：德琪医药有限公司是一家专注于创新抗肿瘤药物的亚太地区临床阶段生物制药公司。该公司主要在亚太地区开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118142854977080e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118142854977080e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06996","BK1574","BK1191","BK1583"],"gpt_icon":0},{"id":"2584023605","title":"决胜港股升浪·牛启东方2026——第十届智通财经资本市场年会邀您共赴资本盛宴","url":"https://stock-news.laohu8.com/highlight/detail?id=2584023605","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584023605?lang=zh_cn&edition=full","pubTime":"2025-11-18 08:53","pubTimestamp":1763427196,"startTime":"0","endTime":"0","summary":"由港美股第一资讯平台智通财经与中资海外私募基金一站式服务平台新智基金网联合主办，“冬日暖阳” 独家承办，S&P Global Market Intelligence、CITIZEN支持的“第十届智通财经资本市场年会”将于2025年12月3-5日联动深圳与香港两地举行。本届年会以\"决胜港股升浪·牛启东方2026\"为主题，设置六大核心议程，汇聚全球资本力量，共探宽松周期尾声的领涨赛道与中国资产长期增长潜力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1370226.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00699","06996","02171","01228","00861","09911","06660","02167","00826","00290","00604","02511","00003","02268","02453","02177","02431","00855","02096","02142","00196","00302","02627","00382","02509","09996","01164","06682","06609","02488","09959","00305","06608","09878","02587","00363","00552","02561","01167","02256","02279","02420","01333","02105","03658","02670","02157","09678","00867","01318"],"gpt_icon":0},{"id":"2584989416","title":"每日卖空追踪 | 德琪医药-B 11月17日卖空量成交16.9万股，卖空比例为8.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584989416","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584989416?lang=zh_cn&edition=full","pubTime":"2025-11-17 16:30","pubTimestamp":1763368235,"startTime":"0","endTime":"0","summary":"德琪医药-B北京时间11月17日，跌3.7%，卖空量成交16.9万股，较上一交易日减少38.32%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117163558a4a72ef8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117163558a4a72ef8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06996","BK1191","BK1583","BK1574"],"gpt_icon":0},{"id":"2581858758","title":"德琪医药-B盘中异动 早盘急速下跌5.02%报4.730港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2581858758","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581858758?lang=zh_cn&edition=full","pubTime":"2025-11-07 10:12","pubTimestamp":1762481528,"startTime":"0","endTime":"0","summary":"2025年11月07日早盘10时12分，德琪医药-B股票出现波动，股价大幅下挫5.02%。截至发稿，该股报4.730港元/股，成交量22.9万股，换手率0.03%，振幅2.61%。资金方面，该股资金流入25.944万港元，流出78.136万港元。德琪医药-B股票所在的药品行业中，整体跌幅为0.71%。德琪医药-B公司简介：德琪医药有限公司是一家专注于创新抗肿瘤药物的亚太地区临床阶段生物制药公司。该公司主要在亚太地区开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110710120894f48a01&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110710120894f48a01&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","06996","BK1583","BK1574"],"gpt_icon":0},{"id":"2579999844","title":"德琪医药-B10月28日主力净流出5.0万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2579999844","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579999844?lang=zh_cn&edition=full","pubTime":"2025-10-28 16:15","pubTimestamp":1761639337,"startTime":"0","endTime":"0","summary":"10月28日, 德琪医药-B股价跌1.80%，报收4.92元，成交金额942.1万元，换手率0.28%，振幅9.78%，量比0.59。德琪医药-B今日主力资金净流出5.0万元，上一交易日主力净流入82.1万元。该股近5个交易日下跌4.76%，主力资金累计净流入169.3万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出358.1万元，其中净流出天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102816190394e17227&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102816190394e17227&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1191","BK1574","06996"],"gpt_icon":0},{"id":"2577584225","title":"德琪医药-B盘中异动 早盘股价大跌5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577584225","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577584225?lang=zh_cn&edition=full","pubTime":"2025-10-23 09:52","pubTimestamp":1761184346,"startTime":"0","endTime":"0","summary":"2025年10月23日早盘09时52分，德琪医药-B股票出现波动，股价大幅下跌5.14%。截至发稿，该股报4.800港元/股，成交量26.15万股，换手率0.04%，振幅6.52%。德琪医药-B股票所在的药品行业中，整体跌幅为0.30%。其相关个股中，三爱健康集团、培力农本方、白花油涨幅较大，振幅较大的相关个股有劲方医药-B、德琪医药-B、泰德医药，振幅分别为6.94%、6.52%、4.25%。德琪医药-B公司简介：德琪医药有限公司是一家专注于创新抗肿瘤药物的亚太地区临床阶段生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251023095226a46f81bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251023095226a46f81bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1583","06996","BK1191"],"gpt_icon":0},{"id":"2576988043","title":"港股异动 | 德琪医药-B(06996)涨超6% 公布ATG-022的I/II期临床研究最新研究成果","url":"https://stock-news.laohu8.com/highlight/detail?id=2576988043","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576988043?lang=zh_cn&edition=full","pubTime":"2025-10-20 14:07","pubTimestamp":1760940441,"startTime":"0","endTime":"0","summary":"消息面上，10月20日，德琪医药宣布，公司在德国柏林举行的欧洲肿瘤内科学会年会上，以壁报形式公布了CLDN18.2抗体偶联药物ATG-022的I/II期临床研究的最新研究成果。目前，ATG-022在中国大陆及澳大利亚的I期剂量扩展阶段研究进展顺利。与此同时，公司正积极推进ATG-022联合用药的临床研究准备工作，以进一步推动其临床开发进程。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1356964.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","06996","BK1583","BK1574"],"gpt_icon":0},{"id":"2576089088","title":"德琪医药-B盘中异动 急速下挫5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2576089088","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576089088?lang=zh_cn&edition=full","pubTime":"2025-10-17 10:19","pubTimestamp":1760667590,"startTime":"0","endTime":"0","summary":"2025年10月17日早盘10时19分，德琪医药-B股票出现异动，股价急速下跌5.00%。截至发稿，该股报5.130港元/股，成交量31.05万股，换手率0.05%，振幅5.37%。德琪医药-B股票所在的药品行业中，整体跌幅为0.65%。其相关个股中，先声药业、长风药业、君圣泰医药-B涨幅较大，振幅较大的相关个股有远大医药、先声药业、绿叶制药，振幅分别为6.02%、5.40%、5.29%。德琪医药-B公司简介：德琪医药有限公司是一家专注于创新抗肿瘤药物的亚太地区临床阶段生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101710195094ce27d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101710195094ce27d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","06996","BK1583","BK1574"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.antengene.com","stockEarnings":[{"period":"1week","weight":-0.0199},{"period":"1month","weight":-0.1122},{"period":"3month","weight":-0.3997},{"period":"6month","weight":0.2137},{"period":"1year","weight":5.6119},{"period":"ytd","weight":5.8154}],"compareEarnings":[{"period":"1week","weight":0.0087},{"period":"1month","weight":0.0058},{"period":"3month","weight":0.0262},{"period":"6month","weight":0.0964},{"period":"1year","weight":0.3336},{"period":"ytd","weight":0.3004}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"德琪医药有限公司是一家专注于创新抗肿瘤药物的亚太地区临床阶段生物制药公司。该公司主要从事生物科技产品的发现、开发、生产及商业化。该公司的主要产品包括用于治疗复发╱难治性多发性骨髓瘤、复发╱难治性弥漫大B细胞淋巴瘤和非小细胞肺癌的ATG-010(selinexor)及用于治疗肝细胞癌和非小细胞肺癌等多种适应症的ATG-008(onatasertib)。该公司主要在亚太地区开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.083349},{"month":2,"riseRate":0.2,"avgChangeRate":0.354616},{"month":3,"riseRate":0.4,"avgChangeRate":0.022852},{"month":4,"riseRate":0.4,"avgChangeRate":-0.055669},{"month":5,"riseRate":0.6,"avgChangeRate":0.040777},{"month":6,"riseRate":0.2,"avgChangeRate":-0.111296},{"month":7,"riseRate":0.2,"avgChangeRate":-0.000904},{"month":8,"riseRate":0.4,"avgChangeRate":-0.030428},{"month":9,"riseRate":0.4,"avgChangeRate":-0.020432},{"month":10,"riseRate":0.4,"avgChangeRate":0.032822},{"month":11,"riseRate":0.6,"avgChangeRate":0.05603},{"month":12,"riseRate":0.333333,"avgChangeRate":0.021057}],"exchange":"SEHK","name":"德琪医药-B","nameEN":"ANTENGENE-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"德琪医药-B(06996)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供德琪医药-B(06996)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"德琪医药-B,06996,德琪医药-B股票,德琪医药-B股票老虎,德琪医药-B股票老虎国际,德琪医药-B行情,德琪医药-B股票行情,德琪医药-B股价,德琪医药-B股市,德琪医药-B股票价格,德琪医药-B股票交易,德琪医药-B股票购买,德琪医药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"德琪医药-B(06996)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供德琪医药-B(06996)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}